ImageneBio (IMA) Retained Earnings (2020 - 2025)
ImageneBio's (IMA) quarterly Retained Earnings came in at $363.1 million in Q4 2025, up 301.83% year-over-year from $90.4 million in Q4 2024, and little changed quarter-over-quarter from $362.9 million in Q3 2025.
Analysis
ImageneBio (IMA) Retained Earnings (2020 - 2025) Analysis & Trends
ImageneBio has disclosed Retained Earnings across 6 years of filings, most recently posting $363.1 million for Q4 2025.
- In Q4 2025, Retained Earnings rose 301.83% year-over-year to $363.1 million; the TTM figure through Dec 2025 stood at $363.1 million (up 301.83% YoY), while the FY2025 annual figure was $363.1 million, up 301.83% from the prior year.
- Retained Earnings came in at $363.1 million for Q4 2025 at ImageneBio, roughly flat from $362.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $458.8 million in Q2 2025 to a low of -$179.9 million in Q4 2024.
- Average Retained Earnings over 5 years is $365.3 million, with a median of $363.0 million recorded in 2025.
- Year-over-year, Retained Earnings surged 417.31% in 2021 and sank 139.79% in 2024.
- Over 5 years, Retained Earnings stood at $353.3 million in 2021, then increased by 2.44% to $361.9 million in 2022, then climbed by 24.93% to $452.1 million in 2023, then slumped by 139.79% to -$179.9 million in 2024, then surged by 301.83% to $363.1 million in 2025.
- Per Business Quant data, the three most recent Retained Earnings figures were $363.1 million in Q4 2025, $362.9 million in Q3 2025, and $458.8 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | -22.28 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 9.53 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 15.69 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 37.62 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 558.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 20.97 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.13 Bn |
| 10 | ImageneBio | 42.89 Mn | -92.46 Mn | - | 363.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 363.09 Mn |
| Sep 30, 2025 | 362.87 Mn |
| Jun 30, 2025 | 458.80 Mn |
| Mar 31, 2025 | 458.34 Mn |
| Dec 31, 2024 | -179.90 Mn |
| Sep 30, 2024 | 456.44 Mn |
| Jun 30, 2024 | 455.42 Mn |
| Mar 31, 2024 | 454.14 Mn |
| Dec 31, 2023 | 452.14 Mn |
| Sep 30, 2023 | 418.49 Mn |
| Jun 30, 2023 | 402.67 Mn |
| Mar 31, 2023 | 363.92 Mn |
| Dec 31, 2022 | 361.92 Mn |
| Sep 30, 2022 | 360.06 Mn |
| Jun 30, 2022 | 358.22 Mn |
| Mar 31, 2022 | 355.69 Mn |
| Dec 31, 2021 | 353.30 Mn |
| Sep 30, 2021 | 351.48 Mn |
| Jun 30, 2021 | 349.96 Mn |
| Mar 31, 2021 | 348.66 Mn |